Literature DB >> 12711691

Stimulation of human DNA polymerase epsilon by MDM2.

Hitomi Asahara1, Ying Li, Jill Fuss, Dale S Haines, Nikolina Vlatkovic, Mark T Boyd, Stuart Linn.   

Abstract

The human DNA polymerase epsilon catalytic subunit consists of a 140-kDa N-terminal domain that contains the catalytic activity and a 120-kDa C-terminal domain that binds to the other subunits and to exogenous peptides, including PCNA and MDM2. We report here that recombinant human MDM2 purified from insect cells or Escherichia coli stimulated the activity of DNA polymerase epsilon up to 10- and 40-fold, respectively, but not those of DNA polymerase beta or Klenow fragment of E.coli DNA polymerase I. Kinetic studies indicated that MDM2 increased the maximum velocity of the reaction, but did not change substrate affinities. The stimulation depended upon the interaction of the N-terminal 166 amino acid residues of MDM2 with the C-terminal domain of the full-length catalytic subunit, since the deletion of 166 amino acids from N-terminal of MDM2 or the removal of the C-terminal domain of DNA polymerase epsilon by trypsin digestion or competition for binding to it by the addition of excess C-terminal fragment eliminated the stimulation. Since DNA polymerase epsilon appears to be involved in DNA replication, recombination and repair synthesis, we suggest that MDM2 binding to DNA polymerase epsilon might be part of a reconfiguration process that allows DNA polymerase epsilon to associate with repair/recombination proteins in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711691      PMCID: PMC154228          DOI: 10.1093/nar/gkg342

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  49 in total

1.  DNA polymerase epsilon is required for coordinated and efficient chromosomal DNA replication in Xenopus egg extracts.

Authors:  S Waga; T Masuda; H Takisawa; A Sugino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase epsilon.

Authors:  N Vlatkovic; S Guerrera; Y Li; S Linn; D S Haines; M T Boyd
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

3.  Structure and function of the fourth subunit (Dpb4p) of DNA polymerase epsilon in Saccharomyces cerevisiae.

Authors:  T Ohya; S Maki; Y Kawasaki; A Sugino
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

4.  Decreased fidelity of DNA polymerase activity isolated from aging human fibroblasts.

Authors:  S Linn; M Kairis; R Holliday
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

5.  Subunit interactions within the Saccharomyces cerevisiae DNA polymerase epsilon (pol epsilon ) complex. Demonstration of a dimeric pol epsilon.

Authors:  R Dua; S Edwards; D L Levy; J L Campbell
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

6.  A single unbranched S-phase DNA damage and replication fork blockage checkpoint pathway.

Authors:  Maria A Marchetti; Sanjay Kumar; Edgar Hartsuiker; Mohamed Maftahi; Antony M Carr; Greg A Freyer; William C Burhans; Joel A Huberman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

7.  Human DNA polymerase epsilon colocalizes with proliferating cell nuclear antigen and DNA replication late, but not early, in S phase.

Authors:  Jill Fuss; Stuart Linn
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

8.  Proteolysis of the human DNA polymerase epsilon catalytic subunit by caspase-3 and calpain specifically during apoptosis.

Authors:  W Liu; S Linn
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

9.  HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins.

Authors:  R A Poot; G Dellaire; B B Hülsmann; M A Grimaldi; D F Corona; P B Becker; W A Bickmore; P D Varga-Weisz
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

10.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

Authors:  R Maya; M Balass; S T Kim; D Shkedy; J F Leal; O Shifman; M Moas; T Buschmann; Z Ronai; Y Shiloh; M B Kastan; E Katzir; M Oren
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

View more
  12 in total

Review 1.  DNA polymerase epsilon: a polymerase of unusual size (and complexity).

Authors:  Zachary F Pursell; Thomas A Kunkel
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2008

2.  The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Kalkunte S Srivenugopal; Subhasree Nag; Shivaputra Patil; Horrick Sharma; Ming-Hai Wang; Hui Wang; John K Buolamwini; Ruiwen Zhang
Journal:  Nat Commun       Date:  2014-10-01       Impact factor: 14.919

3.  MDM2 regulates dihydrofolate reductase activity through monoubiquitination.

Authors:  Maria Maguire; Paul C Nield; Timothy Devling; Rosalind E Jenkins; B Kevin Park; Radoslaw Polański; Nikolina Vlatković; Mark T Boyd
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

4.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03

5.  Identification of a new class of MDM2 inhibitor that inhibits growth of orthotopic pancreatic tumors in mice.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Ming-Hai Wang; Horrick Sharma; Shivaputra Patil; Jianwei Zhou; Hui Wang; Debabrata Mukhopadhyay; John K Buolamwini; Ruiwen Zhang
Journal:  Gastroenterology       Date:  2014-07-10       Impact factor: 22.682

6.  Therapeutic considerations for Mdm2: not just a one trick pony.

Authors:  Jason A Lehman; Jacob A Eitel; Christopher N Batuello; Lindsey D Mayo
Journal:  Expert Opin Drug Discov       Date:  2008-11       Impact factor: 6.098

7.  Functional analysis of Drosophila DNA polymerase ε p58 subunit.

Authors:  Ritsuko Sahashi; Risa Matsuda; Osamu Suyari; Mieko Kawai; Hideki Yoshida; Sue Cotterill; Masamitsu Yamaguchi
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

8.  The MDM2-p53 pathway revisited.

Authors:  Subhasree Nag; Jiangjiang Qin; Kalkunte S Srivenugopal; Minghai Wang; Ruiwen Zhang
Journal:  J Biomed Res       Date:  2013-06-06

9.  Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling.

Authors:  A K M Azad; Alfons Lawen; Jonathan M Keith
Journal:  BMC Syst Biol       Date:  2015-01-20

10.  The potential mechanism of extracellular high mobility group box-1 protein mediated p53 expression in immune dysfunction of T lymphocytes.

Authors:  Ying-Yi Luan; Min Jia; Hui Zhang; Fu-Jun Zhu; Ning Dong; Yong-Wen Feng; Ming Wu; Ya-Lin Tong; Yong-Ming Yao
Journal:  Oncotarget       Date:  2017-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.